5-(Bromomethyl)-2,3-dihydro-1H-indene

Catalog No.: 
ACEBCR068
CAS No.: 
501649-52-1
Molecular Formula: 
C10H11Br
Molecular Weight: 
211.10
5-(Bromomethyl)-2,3-dihydro-1H-indene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%
250mg95%
1g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Bromomethyl)-2,3-dihydro-1H-indene
IUPAC Name5-(bromomethyl)-2,3-dihydro-1H-indene
Molecular FormulaC10H11Br
Molecular Weight211.10
SMILESBrCC1=CC2=C(CCC2)C=C1
InChI KeyNTBYJOFMYKKLQE-UHFFFAOYSA-N
Synonym5-Bromomethyl-indan;1H-INDENE, 5-(BROMOMETHYL)-2,3-DIHYDRO;5-(bromomethyl)-2,3-dihydro-1H-indene;5-(bromomethyl)-2,3-dihydro-1H-indacen;5-(bromomethyl)indane
CAS No.501649-52-1

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314-H335
Precautionary Statement(s)
P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEBCR068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBPRL587 route compound structure diagram
    ACBPRL587874-35-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEBCR068 route product structure diagram
    ACEBCR068501649-52-1In Stock
Inquiry

2. ACEBCR068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXUP973 route compound structure diagram
    ACCXUP97351632-06-5In Stock
  4. Then
  5. ACEBCR068 route product structure diagram
    ACEBCR068501649-52-1In Stock
Inquiry

3. ACEBCR068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEBCR068 route product structure diagram
    ACEBCR068501649-52-1In Stock
Inquiry

Comments (0)